Brind.

William Blair inquired about revised guidance philosophy from NeoGenomics on August 12, 2025.

1 report, 1 independent Updated Aug 12

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

NeoGenomics William P. Blair

Keep exploring

The entities involved

NeoGenomics
cancer genetics diagnostic testing company based in Fort Myers, Florida, USA
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
William P. Blair
American astrophysicist
- Watsco reported margin impacts due to subdued international sales in Mexico, with analysts questioning volume trends.Sun 06:23

Coverage

Newest first; wire copies grouped

Aug 12StockStoryNeoGenomics’s Q2 Earnings Call: Our Top 5 Analyst Questions NeoGenomics’ second quarter was met with a significant negative market reaction, reflecting disappointment over a shortfall in revenue comp